316 related articles for article (PubMed ID: 5416937)
21. Studies on the physiologic disposition and activity of phenylpropanolamines in the mouse.
Levitt M; Cumiskey WR; Shargel L
Drug Metab Dispos; 1974; 2(2):187-93. PubMed ID: 4150999
[No Abstract] [Full Text] [Related]
22. Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones.
Brodie BB; Costa E; Groppetti A; Matsumoto C
Br J Pharmacol; 1968 Nov; 34(3):648-58. PubMed ID: 5726793
[TBL] [Abstract][Full Text] [Related]
23. Peripheral noradrenaline and adrenergic transmission in the rat.
Spriggs TL
Br J Pharmacol Chemother; 1966 Jan; 26(1):271-81. PubMed ID: 5919511
[No Abstract] [Full Text] [Related]
24. The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine.
Abrams WB; Solomon HM
Clin Pharmacol Ther; 1969; 10(5):702-9. PubMed ID: 4390109
[No Abstract] [Full Text] [Related]
25. The release of guanethidine and bethanidine by splenic nerve stimulation: a quantitative evaluation showing dissociation from adrenergic blockade.
Shand DG; Morgan DH; Oates JA
J Pharmacol Exp Ther; 1973 Jan; 184(1):73-80. PubMed ID: 4686017
[No Abstract] [Full Text] [Related]
26. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
Jonsson G; Malmfors T; Sachs C
Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
[No Abstract] [Full Text] [Related]
27. Uptake, retention and metabolism of H 3 -tyramine in rat atria.
Steinberg MI; Smith CB
J Pharmacol Exp Ther; 1971 Jan; 176(1):139-48. PubMed ID: 4936457
[No Abstract] [Full Text] [Related]
28. The antagonism of adrenergic neurone blockade by amphetamine and dexamphetamine in the rat and guinea-pig.
Follenfant MJ; Robson RD
Br J Pharmacol; 1970 Apr; 38(4):792-801. PubMed ID: 5441791
[TBL] [Abstract][Full Text] [Related]
29. The influence of sympathetic nervous activity on cardiac catecholamine levels.
Bhagat B
J Pharmacol Exp Ther; 1967 Jul; 157(1):74-80. PubMed ID: 4382101
[No Abstract] [Full Text] [Related]
30. The uptake of adrenergic neurone blocking drugs.
Wilson J
Br J Pharmacol; 1970 Sep; 40(1):159P-160P. PubMed ID: 5487013
[No Abstract] [Full Text] [Related]
31. The effects of guanethidine, bretylium and debrisoquine on the accumulation of noradrenaline in constricted postganglionic sympathetic nerves in vitro.
Tomlinson DR; Mayor D
Eur J Pharmacol; 1973 Feb; 21(2):161-70. PubMed ID: 4696099
[No Abstract] [Full Text] [Related]
32. Some factors affecting the neuron blocking action of guanethidine, xylocholine, bretylium and debrisoquin.
Prasad CM; Shah DS; Gulati OD
Jpn J Pharmacol; 1973 Dec; 23(6):805-11. PubMed ID: 4544694
[No Abstract] [Full Text] [Related]
33. 6-hydroxydopamine, 6-hydroxydopa and degeneration of adrenergic nerves.
de Champlain J; Nadeau R
Fed Proc; 1971; 30(3):877-85. PubMed ID: 4324975
[No Abstract] [Full Text] [Related]
34. Studies on the dual action of guanethidine in sympathetic nerves.
Lundborg P; Stitzel RE
Acta Physiol Scand; 1968; 72(1):100-7. PubMed ID: 5655744
[No Abstract] [Full Text] [Related]
35. Enhancement of H3-norepinephrine accumulation in rat vas deferens by cocaine, imipramine, and desmethylimipramine.
Maître L; Staehelin M
Experientia; 1968 Jul; 24(7):671-2. PubMed ID: 5705220
[No Abstract] [Full Text] [Related]
36. [Release and biosynthesis of noradrenaline in the organs controlled by the nervous system].
Ando N
Nihon Yakurigaku Zasshi; 1970 Sep; 66(5):530-50. PubMed ID: 5529893
[No Abstract] [Full Text] [Related]
37. Blocking H 3 -Norepinephrine uptake and some guanethidine-induced effects with tricyclic psychotherapeutic drugs.
Koe BK; Constantine JW
Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):71-80. PubMed ID: 5010834
[No Abstract] [Full Text] [Related]
38. RECENT VIEWS ON MECHANISMS FOR LOWERING SYMPATHETIC TONE.
BRODIE BB
Circulation; 1963 Nov; 28():970-86. PubMed ID: 14085298
[No Abstract] [Full Text] [Related]
39. [On the mechanism of the adrenergic blocking action of bretylium and guanethidine].
Haeusler G; Haefely W; Huerlimann A
Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):241-3. PubMed ID: 4242393
[No Abstract] [Full Text] [Related]
40. Interactions of bretylium and other drugs on guinea-pig atria: evidence for inhibition of neuronal monoamine oxidase by bretylium.
Furchgott RF; Garcia PS; Wakade AR; Cervoni P
J Pharmacol Exp Ther; 1971 Nov; 179(2):171-85. PubMed ID: 4399958
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
